Data as of Mar 07
| +0.15 / +2.66%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a -4.84% decrease from the last price of 5.78.
The current consensus among 1 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.